Edgestream Partners’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.87M Buy
138,130
+47,303
+52% +$1.55M 0.13% 310
2025
Q4
$3.4M Buy
90,827
+77,436
+578% +$2.55M 0.1% 383
2025
Q3
$369K Buy
+13,391
New +$461K 0.01% 770
2025
Q2
Sell
-75,770
Closed -$2.51M 936
2025
Q1
$2.51M Buy
+75,770
New +$2.72M 0.09% 426
2024
Q2
Sell
-60,281
Closed -$2.02M 929
2024
Q1
$2.02M Buy
60,281
+11,336
+23% +$364K 0.1% 335
2023
Q4
$1.58M Buy
48,945
+31,302
+177% +$874K 0.11% 301
2023
Q3
$578K Sell
17,643
-31,429
-64% -$1.09M 0.05% 560
2023
Q2
$1.73M Buy
+49,072
New +$1.69M 0.16% 222

Other funds holding HRMY